These Undervalued Smallcap Warrants May Be Poised For Gains

Spotlight Growth - Penny Stocks, Small Cap Stocks, Micro-Cap and Micro Cap Stocks, Stock Exchange, NASDAQ, Crypto, BitCoin, DogeCoin, Ai, Artificial Intelligence, Chat GPT, OpenAi, Open Ai, ASURE Software, Trending, Now, Breaking News, BioTech, Data, Analytics, Technology, Big Tech, Banking, SVB, Bank Closures, Failures, Finance, Stock Market News, WeBull, RobinHood, Reddit Traders, Trading, Investing, Investors, Investment, Investments, Day Trading, Real Estate, VC, Venture Capital, Private Equity, Firm, Firms, OTC Markets, Public, Private, OTCQB, GOOG, APPLE, Shareholders, Stakeholders, Shares, Finance Education, Blog, Articles, Consumer Goods, Pharma, Commodities, Precious Metals, Gold, Silver, Cannabis, CBD, Lithium, Electric Vehicles, Solar, Tesla, Charging, EV, Cloud Computing, Wall Street Bets, Sports Betting, Economy, Economics, IPO, Trade Ideas, Intellectual Property Rights, Private Placement, Crowd Funding, Fundraising, Meta, Metaverse, Web 3, Cyber, Cybersecurity, Cyber Security, Aircraft, VPN, Yahoo Finance, Benzinga, BarChart.

A warrant is versatile trading instrument which gives investors the right (but not the obligation) to initiate exposure to a stock at a predetermined price at some date in the future. In this way, warrants are similar to stock options. But warrants differ from stock options because they are issued by the companies themselves and they involve the creation of new shares for future transactions.

Warrants are sometimes included as part of an IPO as a way of raising confidence or attracting investors to the offering. A well-known example of a warrant issuance occurred during the government bailout of Chrysler in the 1980s, when the the company included 14.4 million warrants as part of its $1.2 billion federal loan agreement. The Chrysler warrants came with an exercise price of $13 and were offered when the stock was trading at only $5 per share. The company may not have though share prices would actually rise that high but the stock actually surged above $30, costing Chrysler $300 million and driving strong gains for taxpayers.

Provectus Biopharmaceuticals, Inc. (OTCMKTS: PVCT) may be in a position to generate even more substantial returns if valuations are able to trade back in-line with their historical averages.

The Knoxville, Tennessee pharmaceutical company recently announced that they have been granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA) for small molecule oncolytic immunotherapy PV-10. The treatment is used during neuroblastoma treatments in pediatric solid tumors. Provectus has managed to show significant improvements in its per-share earnings performances over the last two years, and the company is expected to show evidence of profitability over the next few quarters.

The Provectus Biopharmaceuticals warrants trade on the OTC market under the symbol “PVCTW” and are convertible into common stock at a strike price of $0.85. The expiration date for the warrants is not until June 19, 2020. Provectus has traded with a somewhat volatile history but with current valuations trading at extreme lows, this type of price behavior may actually work in the favor of the bulls. Positive news releases an improvements in earnings per share increase the chances for profitability in the position.

A similar valuation story can be seen with Optex Systems Holdings, Inc. (OTCMKTS: OPXS), which manufacturers precision optical sighting systems for military and commercial applications. The company recently announced the addition of over $7 Million in new contracts during the fourth fiscal quarter of 2018. Most of these contracts deal with the construction of Laser Protected Periscopes but also include deals for Non-Laser Protected Periscopes and various Sighting Systems.

The Optex Systems warrants trade on the OTC market under the symbol “OPXXW” and are convertible into common stock at a strike price of $1.50. The expiration date for the warrants is not until August 26, 2019. While the stock has seen significant declines during the last decade, consistency in the company’s order backlog suggests that we could see valuations turn up again from their currently depressed levels as we head into next year.

Disclaimer: The author and Spotlight Growth has no positions in any of the stocks mentioned in this article. Nor does either party currently have any relationship, or any other conflicts of interest, with any of the companies mentioned in this article. This content is meant for informational and entertainment purposes only and should not be meant as a recommendation to buy or sell any securities. Please visit a licensed financial representative to determine what investments are right for you.

Article By: Ric Cox

These Undervalued Smallcap Warrants May Be Poised For Gains

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

Vision Marine (NASDAQ: VMAR): An Innovative, Revenue-Producing Company Riding the Electric Boating Growth Trend

Decentraland (MANA) is the Proof of Concept for the Emerging Metaverse

Alfi, Inc. (NASDAQ: ALF) Climbs 51% After Entering Into Agreement with Miami-Based Fulfillment & Distribution Center For its Ridesharing Digital Tablet Rollout

Telcoin (TEL) Continues to Demonstrate Fundamental Progress, Displaying Bullish Technical Setup

Grove Collaborative (NYSE: GROV) Expands Retail Distribution Footprint Into 2,200 Additional Stores

The Metaverse is Exploding in Popularity and Growth

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

Safe-T Group Ltd. (NASDAQ: SFET) to Participate at A.G.P.’s Virtual Emerging Growth Technology Conference on February 4, 2021

Nvidia Announces New Chip Specifically For Ethereum Mining

Sortis Holdings, Inc. (OTC Pink: SOHI) Announces Results for Second Quarter 2020

Medical Marijuana Coming Soon to Virginia

SushiSwap (SUSHI) Appropriates Uniswap’s Liquidity Pool by Preempting Native Token Release

Europe Shows Signs of Warming to SPACs

Singapore’s Journey to Becoming a Biotech Powerhouse

SeaStar Medical (NASDAQ: ICU) Earns Third FDA Breakthrough Device Designation for Selective Cytopheretic Device

Exploring What Led to a 3,000% Surge in Shares of Tempest Therapeutics (NASDAQ: TPST)

Vivos Therapeutics (NASDAQ: VVOS) Secures Strategic Alliances to Enhance Clear Aligner Offerings and Bolster Revenue Streams

Shares of Soleno Therapeutics (NASDAQ: SLNO) Surge Over 500% After Its DCCR Candidate Shows Promise in PWS Clinical Trials

Understanding EBITDA and Adjusted EBITDA: A View Into Asure’s (NASDAQ: ASUR) Recent Financial Performance

From Microsoft to Travel Tech: VCI Global’s (NASDAQ: VCIG) Expanding AI Horizons

Singapore’s Leap into the Future of Cell and Gene Therapies

Asure (NASDAQ: ASUR) Completes Capital Raise to Fuel High-Interest Debt Reduction, Craig-Hallum Analyst Praises Move and Estimates Bullish Outcome

Asure (NASDAQ: ASUR) Reports Massive 50% Y/Y Revenue Growth During Q2 2023, Raises $40 Million to Pay Off High-Interest Debt and Fund Acquisitions

Recent News

Singapore’s Journey to Becoming a Biotech Powerhouse

SeaStar Medical (NASDAQ: ICU) Earns Third FDA Breakthrough Device Designation for Selective Cytopheretic Device

Categories

Site Navigation